PATENT CLAIM ANALYSIS

Application Number: 15555446
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "145100"]

Abstract:
The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.

Claim (Index 88):
The method of  claim 87 , wherein said IL-18 associated disease or disorder is a pediatric autoinflammatory disease or condition and/or the symptoms associated with said disease or condition.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.55882
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14017561', '15164508', '14649297', '14146566', '13676511']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7824847256020595
- 35 USC 102 Novelty (BERT): 0.5331267521376598
- Combined Prediction Score: 0.7575489282556196
- Mean Citation Score: 335.13133000000005
- Max Citation Score: 364.11945
- Similarity Product: 235.46863477610347

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test